The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis , the bookrunner on the deal said on Wednesday.

Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 billion).. The Sandoz Family Foundation, through the vehicle Emasan AG ...

Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss pharmaceutical firm Novartis to raise up to $3 billion in an accelerated ...

Investing.com -- The investment entity of the Sandoz (SIX: SDZ) family, Emasan AG, has sold a substantial portion of its stake in Swiss pharmaceutical giant Novartis (SIX: NOVN), netting 2.6 ...

The Sandoz family foundation, which holds a stake in Swiss pharmaceutical giant Novartis AG, sold 2.6 billion Swiss francs ...

--Hermes appears well-placed to acquire the watchmaking division of the Sandoz Family Foundation, French broadcaster BFM Business reports citing an unnamed source. --Hermes has beaten LVMH Moet ...

ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis, the bookrunner on the deal ...

The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis, the bookrunner on the deal said on Wednesday.

Sandoz family to get $2.9 billion from offloading part of its Novartis stake. Open in App ...

The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis, the bookrunner on the deal said on Wednesday. Emasan ...